Anaplastic Thyroid Cancer

• CLINICAL_TRIALS trial_result · 2025-09-05
  Clinical Trial Update: Efficacy of Pembrolizumab and Lenvatinib in Patients With Anaplastic Thyroid Cancer [Phase 2]

  A Phase 2 clinical trial update assessing the combination of pembrolizumab and lenvatinib in patients with anaplastic thyroid cancer; the st…

• CLINICAL_TRIALS trial_result · 2025-05-08
  Clinical Trial Update: Surufatinib in Combination With Tislelizumab in Subjects With Advanced Solid Tumors [Phase 1, Phase 2]

  The Phase 1/2 trial of surufatinib in combination with tislelizumab for advanced solid tumors has been terminated. Results were posted on 20…

• CLINICAL_TRIALS trial_result · 2024-09-19
  Clinical Trial Update: Abemaciclib in Metastatic or Locally Advanced Anaplastic/Undifferentiated Thyroid Cancer [Phase 2]

  Phase 2 trial of abemaciclib in metastatic or locally advanced anaplastic/undifferentiated thyroid cancer has completed with results posted.

• CLINICAL_TRIALS trial_result · 2024-04-19
  Clinical Trial Update: Nexavar for Neoadjuvant Treatment of Anaplastic Thyroid Cancer [Phase 2]

  Phase 2 trial update for Nexavar as neoadjuvant treatment in anaplastic thyroid cancer has completed.

• CLINICAL_TRIALS trial_result · 2024-01-12
  Clinical Trial Update: A Phase I/II Study of MLN0128 in Metastatic Anaplastic Thyroid Cancer and Incurably Poorly Differentiated or Radioidodine Refractory Differentiated Thyroid Cancer [Phase 1, Phase 2]

  Phase I/II trial of MLN0128 in metastatic anaplastic thyroid cancer and poorly differentiated or radioiodine-refractory differentiated thyro…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2023-08-21
  Clinical Trial Update: The Efficacy and Safety of HLX208 in Advanced Anaplastic Thyroid Cancer (ATC) With BRAF V600 Mutation [Phase 1, Phase 2]

  Clinical trial update for HLX208 in advanced anaplastic thyroid cancer with BRAF V600 mutation across Phase 1/Phase 2 cohorts; status is cur…

• CLINICAL_TRIALS trial_result · 2022-12-21
  Clinical Trial Update: PD-1 Inhibitor and Anlotinib Combined With Multimodal Radiotherapy in Recurrent or Metastatic Anaplastic Thyroid Cancer [Phase 2]

  A Phase 2 clinical trial evaluating PD-1 inhibitor plus anlotinib with multimodal radiotherapy for recurrent or metastatic anaplastic thyroi…

• CLINICAL_TRIALS trial_result · 2022-02-10
  Clinical Trial Update: Pembrolizumab in Anaplastic/Undifferentiated Thyroid Cancer [Phase 2]

  Phase 2 trial update for pembrolizumab in anaplastic thyroid cancer has completed with results posted.

• CLINICAL_TRIALS trial_result · 2021-09-29
  Clinical Trial Update: Phase I/II Study of PDR001 in Patients With Advanced Malignancies [Phase 1, Phase 2]

  Phase I/II trial update for PDR001 in advanced malignancies completed with posted results.

• CLINICAL_TRIALS trial_result · 2020-10-05
  Clinical Trial Update: Study of HX008 for the Treatment of Anaplastic Thyroid Cancer (ATC) [Phase 2]

  Phase 2 clinical trial update for HX008 in anaplastic thyroid cancer.

• CLINICAL_TRIALS trial_result · 2020-09-16
  Clinical Trial Update: A Phase 1/2 Study of CS7017, an Oral PPARγ Agonist, in Combination With Paclitaxel [Phase 1, Phase 2]

  Phase 1/2 study of CS7017, an oral PPARγ agonist, in combination with paclitaxel for Anaplastic Thyroid Cancer; study terminated with result…

• CLINICAL_TRIALS trial_result · 2020-06-17
  Clinical Trial Update: Phase II Study Assessing the Efficacy and Safety of Lenvatinib for Anaplastic Thyroid Cancer [Phase 2]

  Phase II study evaluating lenvatinib for anaplastic thyroid cancer has completed.

• CLINICAL_TRIALS trial_result · 2019-12-27
  Clinical Trial Update: Inolitazone Dihydrochloride and Paclitaxel in Treating Patients With Advanced Anaplastic Thyroid Cancer [Phase 2]

  Phase 2 trial results for the combination of inolitazone dihydrochloride and paclitaxel in advanced anaplastic thyroid cancer; the update re…

• CLINICAL_TRIALS trial_result · 2019-11-18
  Clinical Trial Update: Phase II Trial of Sorafenib (Nexavar) in Patients With Advanced Thyroid Cancer [Phase 2]

  Phase II trial of Sorafenib (Nexavar) in advanced thyroid cancers completed; results posted in 2019.

• CLINICAL_TRIALS trial_result · 2014-01-16
  Clinical Trial Update: Sorafenib Tosylate in Treating Patients With Locally Advanced, Metastatic, or Locally Recurrent Thyroid Cancer [Phase 2]

  Phase 2 trial of sorafenib tosylate in locally advanced, metastatic, or locally recurrent thyroid cancers was terminated.

• CLINICAL_TRIALS trial_result · 2012-08-10
  Clinical Trial Update: Sorafenib in Treating Patients With Advanced Anaplastic Thyroid Cancer [Phase 2]

  Phase 2 trial of sorafenib in advanced anaplastic thyroid cancer and recurrent thyroid cancer has been terminated with results posted in 201…